Principal Investigator
Linda Hong, MD
Loma Linda University Cancer Center
Total Trials
1
As PI
1
Completed
1
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Phase 31
Trial Status
Completed1
Role Distribution
Principal Investigator1
PI Rate100%
Activity Timeline
Clinical Trials (1)
Conventional Prophylactic Oral Dexamethasone vs Short-course IV Dexamethasone in Paclitaxel Hypersensitivity
Hypersensitivity Reactions
PrincipalinvestigatorStart date: 2018-08-08
Research Network
Collaboration Network
1 collaborators·0 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Loma Linda University Cancer Center
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
4 similar investigators found
James M Gregory, MD
The University of Texas Health Science Center, Houston
4 trials
Shared therapeutic areas:
Hypersensitivity Reactions
Similarity Score30%
Esther Steveling-Klein, Dr. med
Allergology, University Hospital Basel
1 trials
Shared therapeutic areas:
Hypersensitivity Reactions
Similarity Score30%
Melanie Dispenza, MD, PhD
Johns Hopkins University
1 trials
Shared therapeutic areas:
Hypersensitivity Reactions
Similarity Score30%
Jorge Ferrer, PhD
Lumicell, Inc.
3 trials
Shared therapeutic areas:
Hypersensitivity Reactions
Similarity Score30%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Conventional Prophylactic Oral Dexamethasone vs Short-course IV Dexamethasone in Paclitaxel Hypersensitivity
Hypersensitivity Reactions
All 1 trials loaded